Virtual immunology laboratory suite
Immersive laboratory experience across 19 workstations: immunofluorescence microscopy, ELISA automation, complement testing, transplant immunology and specialised assays.
Virtual Immunology Lab Suite is available to premium subscribers and trial users.
Immunology LIMS
Advanced laboratory information management for immunology with cross-departmental references and complete validation workflow.
Immunology LIMS System is available to premium subscribers and trial users.
Autoimmunity analysis
Interactive tools for autoantibody screening, ANA / ENA / ANCA patterns, and clinical interpretation with disease associations.
Antinuclear Antibody (ANA) Patterns
Common immunofluorescence patterns and their clinical significance
Homogeneous
Uniform staining of nucleus; associated with SLE and drug-induced lupus
Speckled
Fine or coarse speckles throughout nucleus; seen in SLE, MCTD, and Sjögren's
Nucleolar
Clumpy staining of nucleoli; associated with systemic sclerosis
Centromere
Discrete speckles; highly specific for limited cutaneous systemic sclerosis (lcSSc)
Laboratory Insight
Pattern recognition should be followed by specific extractable nuclear antigen (ENA) testing to identify the exact autoantibody specificity. The immunofluorescence pattern provides important initial diagnostic clues.
Flow cytometry guide
Immunophenotyping, gating strategies and clinical applications of flow cytometry in diagnosis: the depth Band 6+ panels expect.
Flow Cytometry Principles
Core concepts of flow cytometry in clinical immunology
Key Components
Flow cytometry analyses multiple characteristics of individual cells simultaneously by suspending cells in a stream of fluid and passing them through an electronic detection apparatus.
Fluidics System
- Creates stream of single cells
- Hydrodynamic focusing aligns cells
- Ensures cells pass through laser one by one
- Controls sample flow rate
- Managed through sheath fluid pressure
Optics System
- Lasers excite fluorochromes
- Optical filters select specific wavelengths
- Forward scatter measures cell size
- Side scatter assesses cell granularity
- Fluorescence detects specific antibody binding
Electronic System
The electronic system converts light signals into electronic signals that can be processed by a computer. The process involves:
Fluorochromes
Commonly used fluorochromes in clinical immunology applications:
(Green)
(Orange ~575nm)
(Tandem Red ~675nm)
(Far Red)
(Blue)
(Red/IR)
(Green)
(UV)
Immunodeficiency guide
Reference for primary and secondary immunodeficiencies with diagnostic pathways and laboratory findings.
Primary Immunodeficiency Disorders
Genetic disorders affecting immune system development and function
Classification Approach
Primary immunodeficiencies (PIDs) are classified based on the affected component of the immune system. They result from genetic mutations affecting immune system development or function.
Severe Combined Immunodeficiency (SCID)
Definition
Group of disorders characterised by severe defects in T cell development, with variable B and NK cell defects.
Key Features
- Profound lymphopenia (especially T cells)
- Recurrent severe infections beginning in early infancy
- Failure to thrive
- Chronic diarrhoea
- Can present with skin rash (maternal T cell engraftment)
Common Subtypes
| Phenotype | Genetic Defect | Inheritance |
|---|---|---|
| T-B-NK+ | RAG1/2, DCLRE1C | AR |
| T-B-NK- | ADA | AR |
| T-B+NK- | IL2RG | X-linked |
| T-B+NK+ | IL7R, CD3 chains | AR |
Antibody Deficiencies
Common Disorders
- X-linked agammaglobulinaemia (BTK deficiency)
- Common Variable Immunodeficiency (CVID)
- Selective IgA Deficiency
- Specific antibody deficiency
- Hyper-IgM syndrome
Clinical Presentation
- Recurrent sinopulmonary infections
- Gastrointestinal infections and disorders
- Autoimmunity (especially in CVID)
- Increased risk of malignancy
- Onset typically after 6 months when maternal antibody wanes
CVID Diagnostic Criteria
- Age > 4 years
- Low IgG and low IgA and/or IgM
- Poor response to vaccines
- Exclusion of secondary causes
Phagocytic Disorders
Key Disorders
- Chronic Granulomatous Disease (NADPH oxidase defects)
- Leukocyte Adhesion Deficiency (CD18, selectin defects)
- Chediak-Higashi Syndrome (LYST mutations)
Clinical Features
- Recurrent bacterial and fungal infections
- Abscesses, pneumonia, osteomyelitis
- Poor wound healing
- Gingivitis and periodontitis
- Granuloma formation (in CGD)
Diagnostic Tests
- DHR or NBT test for CGD
- Flow cytometry for CD18 expression in LAD
- Peripheral blood smear for giant granules in CHS
- Genetic testing
Complement Deficiencies
Pathway Defects
- Classical pathway (C1q, C2, C4): Autoimmunity, immune complex disease
- Alternative pathway (Factor D, properdin): Neisserial infections
- Terminal pathway (C5-C9): Recurrent meningococcal infections
- Regulatory proteins (C1-INH): Hereditary angioedema
Clinical Associations
- SLE-like syndrome (early pathway defects)
- Recurrent bacterial infections (especially encapsulated)
- Neisserial infections (terminal pathway)
- Angioedema (C1-INH deficiency)
Diagnostic Approach
- CH50 (classical pathway activity)
- AP50 (alternative pathway activity)
- Individual complement component quantification
- Genetic testing
Immunology data visualisation
Interactive charts and graphs showcasing key immunological parameters and antibody patterns.
Autoantibody Prevalence in Autoimmune Diseases
Illustrative, approximate percentages for teaching only. Reported positivity varies widely by cohort, disease stage and assay.
Key Clinical Insights:
- Anti-dsDNA or anti-Sm antibodies score 6 points (counted once) in the 2019 EULAR/ACR classification criteria for SLE (Aringer et al., 2019), which require an ANA titre of at least 1:80 on HEp-2 cells as the entry criterion
- Anti-Sm antibodies are highly specific for SLE but are found in only a minority of patients
- Anti-CCP antibodies are more specific than rheumatoid factor for RA: a meta-analysis reported pooled sensitivity of 67% and specificity of 95% (Nishimura et al., Ann Intern Med 2007)
- Anti-Ro (SSA) is the predominant autoantibody marker in Sjögren's syndrome
- Anti-Scl-70 (anti-topoisomerase I) is associated with the diffuse cutaneous form of systemic sclerosis
- Cross-reactivity between diseases reflects shared pathogenic pathways
Immunology quick guide
Essential knowledge areas for immunology, from foundational concepts to specialised techniques.
Innate Immunity
The first line of defence against pathogens
Components of Innate Immunity
Innate immunity represents the body's first line of defence against pathogens, characterised by rapid, non-specific responses that do not confer long-lasting protection.
Physical & Chemical Barriers
- Epithelial surfaces
Skin and mucous membranes form tight junctions to prevent pathogen entry.
- Mucociliary clearance
Mucus entraps pathogens while cilia propel them out of the respiratory tract.
- Antimicrobial peptides
Defensins, cathelicidins disrupt microbial membranes. Found in skin, gut, lungs.
- Chemical defences
Gastric acid, lysozyme, low pH of skin, vaginal secretions.
Cellular Components
- Neutrophils
First cells to migrate to infection sites; phagocytose and destroy pathogens.
- Monocytes/Macrophages
Tissue phagocytes; clear debris, present antigens, secrete cytokines.
- Dendritic cells
Professional antigen-presenting cells bridging innate and adaptive immunity.
- NK cells
Detect and kill virus-infected cells and tumour cells without prior sensitisation.
- Mast cells & Basophils
Release histamine and other mediators; important in allergic responses.
Pattern Recognition
Innate immune cells recognise pathogens through Pattern Recognition Receptors (PRRs) that bind to Pathogen-Associated Molecular Patterns (PAMPs), conserved structures present on microbes but not host cells.
Key PRR Families:
- Toll-like receptors (TLRs)
Cell surface (TLR1, 2, 4, 5, 6) and endosomal (TLR3, 7, 8, 9) receptors.
- NOD-like receptors (NLRs)
Cytoplasmic sensors forming inflammasomes when activated.
- RIG-I-like receptors (RLRs)
Detect viral RNA in cytoplasm.
- C-type lectin receptors
Recognise carbohydrate structures on pathogens.
Common PAMPs:
- Lipopolysaccharide (LPS)
Gram-negative bacterial cell wall component; activates TLR4.
- Peptidoglycan
Bacterial cell wall component; activates TLR2.
- Flagellin
Bacterial flagella protein; activates TLR5.
- Double-stranded RNA
Viral replication intermediate; activates TLR3.
- CpG DNA
Unmethylated bacterial DNA motifs; activate TLR9.
Complement System
The complement system is a cascade of plasma proteins that enhance (complement) antibody function and innate immunity through pathogen opsonisation, inflammatory response stimulation, and direct pathogen lysis.
Classical Pathway
- Activated by antigen-antibody complexes
- C1q binds Fc region of antibodies
- Activates C1r and C1s proteases
- C4 and C2 cleavage forms C3 convertase
- Links adaptive and innate immunity
Alternative Pathway
- Activated by microbial surfaces
- Spontaneous C3 hydrolysis ("tickover")
- Factor B and D form C3 convertase
- Properdin stabilises the convertase
- Rapid response without antibodies
Lectin Pathway
- Initiated by mannose-binding lectin
- Recognises carbohydrates on microbes
- Activates MASP proteases (like C1r/C1s)
- Cleaves C4 and C2
- Independent of antibodies
Terminal Pathway Functions:
Clinical Relevance
- Defects in innate immunity components typically present with recurrent bacterial infections
- Chronic granulomatous disease (NADPH oxidase defects) causes impaired neutrophil killing
- Complement deficiencies associate with specific infection patterns and autoimmune diseases
- Pattern recognition receptor polymorphisms influence susceptibility to infectious diseases
- Excessive innate immune activation contributes to inflammatory and autoimmune conditions
Sources and guidance
This hub's content aligns with the UK's professional and regulatory references for the specialty: